Research Collaborations
Partner with SIO to Develop Innovative Research Content and Programs
Addressing a Critical Need for Interventional Oncology (IO) Research
Interventional Oncology (IO) is playing an increasingly central role in cancer care. This growth has underscored an opportunity to optimize and expand the role of IO even further through cutting-edge basic science, translational, and clinical research. High-quality clinical trials hold the potential to change guidelines that determine practice and reimbursement. These trials develop on a backbone of pre-clinical science that establishes pathways and mechanisms to enable the integration of image-guided therapies into the continuum of cancer care. The Society of Interventional Oncology’s (SIO) physician community is leading the way in supporting and facilitating this critical research. A strategic priority for our society, we seek to identify new opportunities for research that will improve outcomes for patients as we continue to build interventional oncology as the fourth pillar of cancer therapy. To realize this goal, we are committed to partnering with industry to support and enable groundbreaking science that seeks to discover and develop innovative approaches in oncology research that will improve access and adoption of these life-changing interventions.
$8 million total research funds raised for preclinical or clinical research
20+ institutions awarded research funding by SIO
20+ investigators funded to date
How Does SIO's Grant Process Work?
SIO Research Opportunities
Connect with us today to begin your research collaboration with SIO.
Contact
Beverlee Galstan
Industry Relations Director
Email / (202) 367-2373
Jena Stack
Executive Director
Email / (312) 673-4751
Research Steering Committee
The SIO Research Steering Committee oversees all SIO research priorities for the year, including oversight and delegation of any appropriate projects to the Clinical Trials Committee, Guidelines Committee, and the Publications Committee. Learn more.
Committee Chair
Terence Gade, MD, PhD
University of Pennsylvania
Vice Chair
Rony Avritscher, MD
University of Texas MD Anderson Cancer Center
Research Advisor
Michael Soulen, MD
University of Pennsylvania
Board Liaison
Sarah White, MD
Medical College of Wisconsin
Greg Nadolski, MD
University of Pennsylvania
NIH Liaison
Brad Wood, MD
NIH
Grant Sub-Committee
Chair
Julius Chapiro, MD
Yale University
Research Development Sub-Committee
Chair
Lynn Savic, MD, PhD
Charité University Berlin
Vice-Chair
Joe Erinjeri, MD, PhD
Memorial Sloan Kettering Cancer Center
NCCN Sub-Committee
Chair
Amy Deipoyli, MD, PhD
Charleston Area Cancer Center
Registries Sub-Committee
Chair
Stephen Solomon, MD
Memorial Sloan Kettering Cancer Center